ImmuCell Corp (ICCC)
5.14
+0.11
(+2.19%)
USD |
NASDAQ |
May 06, 15:18
ImmuCell Max Drawdown (5Y): 65.70% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 65.70% |
March 31, 2024 | 65.70% |
February 29, 2024 | 65.70% |
January 31, 2024 | 65.70% |
December 31, 2023 | 65.70% |
November 30, 2023 | 65.70% |
October 31, 2023 | 65.70% |
September 30, 2023 | 65.70% |
August 31, 2023 | 65.70% |
July 31, 2023 | 65.70% |
June 30, 2023 | 65.70% |
May 31, 2023 | 65.70% |
April 30, 2023 | 65.70% |
March 31, 2023 | 65.70% |
February 28, 2023 | 65.70% |
January 31, 2023 | 65.70% |
December 31, 2022 | 65.70% |
November 30, 2022 | 65.70% |
October 31, 2022 | 65.70% |
September 30, 2022 | 65.70% |
August 31, 2022 | 65.70% |
July 31, 2022 | 65.70% |
June 30, 2022 | 65.70% |
May 31, 2022 | 65.70% |
April 30, 2022 | 65.70% |
Date | Value |
---|---|
March 31, 2022 | 65.70% |
February 28, 2022 | 65.70% |
January 31, 2022 | 65.70% |
December 31, 2021 | 65.70% |
November 30, 2021 | 65.70% |
October 31, 2021 | 65.70% |
September 30, 2021 | 65.70% |
August 31, 2021 | 65.70% |
July 31, 2021 | 65.70% |
June 30, 2021 | 65.70% |
May 31, 2021 | 65.70% |
April 30, 2021 | 65.70% |
March 31, 2021 | 65.70% |
February 28, 2021 | 65.70% |
January 31, 2021 | 65.70% |
December 31, 2020 | 65.70% |
November 30, 2020 | 65.70% |
October 31, 2020 | 65.70% |
September 30, 2020 | 65.70% |
August 31, 2020 | 65.70% |
July 31, 2020 | 65.70% |
June 30, 2020 | 65.70% |
May 31, 2020 | 65.70% |
April 30, 2020 | 65.70% |
March 31, 2020 | 65.70% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
55.66%
Minimum
May 2019
65.70%
Maximum
Mar 2020
64.08%
Average
65.70%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -14.03 |
Beta (5Y) | 0.6038 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 46.32% |
Historical Sharpe Ratio (5Y) | -0.1576 |
Historical Sortino (5Y) | -0.3546 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.42% |